AATec Medical

AATec Medical is a biotechnology company that develops a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, viral infections, and rare diseases. It has already demonstrated proof of principle in several indications and is currently preparing for the proof-of-concept clinical trial of its first candidate product, ATL-105, for inhalation application in respiratory diseases.